Literature DB >> 27549356

Prostate cancer: Targeting the ribosome in advanced disease.

Annette Fenner.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27549356     DOI： 10.1038/nrurol.2016.162

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer.

Authors:  Richard J Rebello; Eric Kusnadi; Donald P Cameron; Helen B Pearson; Analia Lesmana; Jennifer R Devlin; Denis Drygin; Ashlee K Clark; Laura Porter; John Pedersen; Shahneen Sandhu; Gail P Risbridger; Richard B Pearson; Ross D Hannan; Luc Furic
Journal:  Clin Cancer Res       Date:  2016-08-02       Impact factor: 12.531
  1 in total
  1 in total

1.  Oncogenic ACSM1 in prostate cancer is through metabolic and extracellular matrix-receptor interaction signaling pathways.

Authors:  Yongchen Guo; Chunna Ren; Wentao Huang; Wancai Yang; Yonghua Bao
Journal:  Am J Cancer Res       Date:  2022-04-15       Impact factor: 5.942
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.